Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Zhengwu LuClinical Research Department, Abbott Vascular, Santa Clara, CA, USAAbstract: Risk assessment during clinical product development needs to be conducted in a thorough and rigorous manner. However, it is impossible to identify all safety concerns during controlled clinical trials. Once a prod...
Main Author: | Zhengwu Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-10-01
|
Series: | Drug, Healthcare and Patient Safety |
Online Access: | http://www.dovepress.com/information-technology-in-pharmacovigilance-benefits-challenges-and-fu-a3630 |
Similar Items
-
Clinical data management: Current status, challenges, and future directions from industry perspectives
by: Zhengwu Lu, et al.
Published: (2010-06-01) -
Past, Present and Future of Pharmacovigilance
by: Derya Kaya, et al.
Published: (2016-06-01) -
The value of direct patient reporting in pharmacovigilance
by: Kruger Paola, et al.
Published: (2020-10-01) -
IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01) -
Current status and future prospects of pharmacovigilance in Pakistan
by: Rabia Hussain, et al.
Published: (2019-05-01)